Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

3.8%

2 terminated out of 53 trials

Success Rate

92.9%

+6.4% vs benchmark

Late-Stage Pipeline

15%

8 trials in Phase 3/4

Results Transparency

19%

5 of 26 completed with results

Key Signals

5 with results93% success

Data Visualizations

Phase Distribution

41Total
Not Applicable (28)
P 1 (3)
P 2 (2)
P 3 (6)
P 4 (2)

Trial Status

Completed26
Recruiting11
Unknown6
Active Not Recruiting3
Not Yet Recruiting3
Terminated2

Trial Success Rate

92.9%

Benchmark: 86.5%

Based on 26 completed trials

Clinical Trials (53)

Showing 20 of 20 trials
NCT05715814Phase 3Recruiting

meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis

NCT05485961Phase 2Recruiting

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis

NCT07426380Phase 1Recruiting

A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function

NCT05558267Not ApplicableNot Yet RecruitingPrimary

Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease

NCT05642364Not ApplicableActive Not RecruitingPrimary

Virtual Reality in Hemodialysis to Improve Psychological Well-being

NCT05774392Withdrawn

An Observational Study of Patients With Chronic Kidney Disease

NCT05525507Phase 1RecruitingPrimary

Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants

NCT05806749Phase 1Active Not RecruitingPrimary

Immunological Tolerance in Patients With Mismatched Kidney Transplants

NCT05738330Not ApplicableRecruitingPrimary

Symptom Monitoring in Hemodialysis

NCT06613568Not ApplicableRecruitingPrimary

Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants

NCT02513303Phase 3Completed

Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes

NCT05311956Not ApplicableRecruitingPrimary

Pain Reduction Using NEurostimulation Study

NCT05425056Phase 3Completed

A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery

NCT05836220Phase 3Completed

Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2

NCT07051447Not ApplicableNot Yet RecruitingPrimary

The Reducing Adverse Outcomes in Dialysis by Adjusting the pRescription for Dialysate Potassium Trial

NCT06581393Not ApplicableCompleted

First Evaluation of the Moda-Flx Hemodialysis System™ in Real World Clinical Settings

NCT03586518RecruitingPrimary

Validating Novel, Non-contrast Cardiac MRI Imaging in Haemodialysis Patients

NCT05418816Not ApplicableActive Not Recruiting

SelfWrap-Assisted Arteriovenous Fistulas

NCT04160507RecruitingPrimary

Duke APOL1 Research Biorepository

NCT05642156Not ApplicableRecruitingPrimary

Hemodynamics in Chronic Hemodialysis Patients Undergoing Isolated Ultrafiltration Compared to Conventional Hemodialysis

Scroll to load more

Research Network

Activity Timeline